Table 3

Relative proportions of susceptibility and resistance profiles from all uropathogens isolated from outpatients at Gulu regional hospital, northern Uganda (n = 82)
Antibiotic (disc potency) Sensitive (95% CI) Intermediate (95% CI) Total a (%) Resistant (95% CI)
Nitrofurantoin (50 μg) 24 (19.5-40.4) 20 (15.6-35.1) 44 (53.7) 38 (35.3-57.7)
Nalidixic acid (30 μg) 19 (14.7-33.8) 20 (15.6-35.1) 39 (47.6) 43 (41.1-63.6)
Cotrim.b (25/125 μg) 12 (7.8-24.2) 10 (6.0-21.3) 22 (26.8) 60 (56.2-82.4)
Amoxicillin (10 μg) 29 (25.1-46.7) 11 (6.9-22.7) 40 (48.8) 42 (39.9-62.4)
Amox-clav c (20/10 μg) 39 (36.4-58.9) 20 (15.6-35.1) 59 (72.0) 23 (18.7-39.1)
Cephalexin (30 μg) 26 (21.9-42.9) 22 (17.6-37.8) 48 (58.5) 34 (30.7-52.9)
Ciprofloxacin (5 μg) 36 (33.0-55.3) 6 (2.7-15.2) 42 (51.2) 40 (37.6-60.1)
Levofloxacin (5 μg) 44 (42.3-64.7) 11 (6.9-22.7) 55 (67.1) 27 (22.9-44.2)
Gentamicin (10 μg) 62 (57.4-84.4) 8 (4.3-18.3) 70 (85.4) 12 (7.8-24.2)
Azithromycin (15 μg) 26 (21.9-42.9) 28 (24.0-45.4) 54 (65.9) 28 (24.0-45.4)

Key: a sum of sensitive and intermediate readings, b cotrimoxazole, c amoxicillin-clavulanic acid.

Odongo et al.

Odongo et al. BMC Infectious Diseases 2013 13:193   doi:10.1186/1471-2334-13-193

Open Data